Intelligent Bio Solutions (INBS)

Intelligent Bio Solutions on one page: short interest, daily short volume, fails to deliver, large holders, earnings dates and insider trades. Listed on Nasdaq.

Download CSV

91K

Short interest

settlement 2026-10-15

1.4

Days to cover

+0.1 days vs prior

17.9%

Short share of volume

2026-11-02

1,807

Fails to deliver

settlement 2026-10-14

Fri 6 Nov

Next earnings

estimated date

Insider flow, 90 days

0 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in INBS is 91,113 shares, down 28,436 shares over the last month. Over the last 48 readings it ranged from 27,026 shares (15 April 2026) to 951,345 shares (15 December 2025). The latest reading sits at the bottom of that range. At the reported average volume of 63K shares a day that is 1.4 days to cover.

Embed this chart.The embed keeps its attribution line.

<iframe src="https://xoomar.com/embed/stocks/inbs" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-10-15	91,113	+56.3%	63,185	1.44
2026-09-30	58,294	-51.2%	41,999	1.39
2026-09-15	119,549	+255.0%	542,875	1.00
2026-08-31	33,673	-68.0%	90,645	1.00
2026-08-14	105,073	+112.8%	110,853	1.00
2026-07-31	49,375	-52.2%	101,425	1.00
2026-07-15	103,339	+21.3%	60,884	1.70
2026-06-30	85,165	-19.9%	37,292	2.28
2026-06-15	106,385	+16.7%	68,709	1.55
2026-05-29	91,169	-38.8%	110,774	1.00
2026-05-15	149,005	+172.7%	247,781	1.00
2026-04-30	54,635	+102.2%	110,125	1.00
2026-04-15	27,026	-39.3%	130,195	1.00
2026-03-31	44,510	+0.2%	42,903	1.04
2026-03-13	44,416	-53.0%	52,272	1.00
2026-02-27	94,421	+181.7%	129,484	1.00
2026-02-13	33,513	-74.6%	90,292	1.00
2026-01-30	131,837	-64.3%	172,319	1.00
2026-01-15	369,460	+187.3%	3,407,692	1.00
2025-12-31	128,608	-86.5%	9,849,558	1.00
2025-12-15	951,345	+4.0%	175,836	5.41
2025-11-28	914,535	-3.2%	114,981	7.95
2025-11-14	944,751	+14.1%	303,877	3.11
2025-10-31	827,745	+57.1%	575,577	1.44
2025-10-15	526,800	+8.6%	134,674	3.91
2025-09-30	485,216	+8.8%	404,858	1.20
2025-09-15	445,948	-10.0%	139,089	3.21
2025-08-29	495,368	-14.1%	119,173	4.16
2025-08-15	576,826	+7.3%	132,476	4.35
2025-07-31	537,783	+4.8%	275,371	1.95
2025-07-15	513,164	-4.4%	238,666	2.15
2025-06-30	536,975	-12.4%	124,602	4.31
2025-06-13	612,760	+15.9%	181,670	3.37
2025-05-30	528,472	-0.7%	82,239	6.43
2025-05-15	532,295	-0.3%	158,829	3.35
2025-04-30	533,974	-1.4%	56,063	9.52
2025-04-15	541,819	+0.5%	77,526	6.99
2025-03-31	538,887	+19.1%	159,729	3.37
2025-03-14	452,314	-0.4%	144,543	3.13
2025-02-28	454,130	+17.3%	289,129	1.57
2025-02-14	387,095	-11.4%	462,501	1.00
2025-01-31	436,829	+12.3%	160,167	2.73
2025-01-15	388,872	-9.0%	64,625	6.02
2024-12-31	427,413	-5.1%	127,896	3.34
2024-12-13	450,490	-11.3%	83,319	5.41
2024-11-29	508,157	-10.0%	162,992	3.12
2024-11-15	564,618	+34.2%	185,793	3.04
2024-10-31	420,637	+13.9%	65,982	6.38

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of INBS volume is 17.9%, down 63.2 points over the last five sessions. Over the last 30 readings it ranged from 16.6% (29 September 2026) to 81.1% (26 October 2026). The latest reading sits at the bottom of that range. The latest reading is 29.3 points below the 30-session average of 47.2%, on 15K shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-11-02	3K	15K	17.9%	0
2026-10-30	7K	12K	55.1%	0
2026-10-29	12K	16K	75.8%	0
2026-10-28	2K	6K	38.5%	0
2026-10-27	5K	7K	73.6%	0
2026-10-26	6K	7K	81.1%	0
2026-10-23	4K	14K	27.8%	0
2026-10-22	2K	4K	54.7%	0
2026-10-21	3K	14K	23.6%	0
2026-10-20	11K	20K	54.8%	200
2026-10-19	2K	5K	34.4%	0
2026-10-16	9K	12K	79.0%	0
2026-10-15	16K	33K	48.2%	0
2026-10-14	27K	44K	62.3%	789
2026-10-13	11K	22K	52.2%	0
2026-10-12	1K	5K	19.8%	0
2026-10-09	4K	9K	47.2%	0
2026-10-08	3K	8K	43.9%	0
2026-10-07	5K	9K	52.8%	0
2026-10-06	31K	61K	50.6%	35
2026-10-05	15K	38K	39.5%	192
2026-10-02	12K	22K	55.8%	0
2026-10-01	5K	18K	27.8%	0
2026-09-30	9K	22K	42.4%	0
2026-09-29	8K	49K	16.6%	4
2026-09-28	11K	14K	80.3%	0
2026-09-25	3K	10K	30.8%	100
2026-09-24	16K	30K	54.5%	0
2026-09-23	6K	17K	34.5%	0
2026-09-22	13K	33K	39.1%	200

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 14 October 2026, the fails-to-deliver balance in INBS is 1,807 shares, up 951 shares over the last settlement date. Over the last 30 readings it ranged from 15 shares (2 April 2026) to 59,283 shares (2 September 2026). The latest reading sits at the bottom of that range.

Settlement	Shares failed	Price	Value
2026-10-14	1,807	$1.48	$3K
2026-09-29	856	$1.65	$1K
2026-09-25	93	$1.71	$159
2026-09-08	484	$2.23	$1K
2026-09-04	22,708	$2.30	$52K
2026-09-03	45,555	$2.47	$113K
2026-09-02	59,283	$2.43	$144K
2026-08-19	1,306	$3.22	$4K
2026-08-14	28,472	$3.00	$85K
2026-08-13	10,764	$2.54	$27K
2026-08-07	1,686	$1.99	$3K
2026-08-06	2,356	$1.79	$4K
2026-08-05	65	$1.81	$118
2026-07-16	8,589	$2.29	$20K
2026-07-14	9,403	$2.30	$22K
2026-06-26	2,765	$2.15	$6K
2026-06-24	591	$2.27	$1K
2026-06-23	5,476	$2.38	$13K
2026-06-22	4,881	$2.29	$11K
2026-06-12	23	$2.40	$55
2026-06-09	6,189	$2.40	$15K
2026-06-04	806	$2.44	$2K
2026-06-03	24,591	$2.54	$62K
2026-05-19	1,900	$3.65	$7K
2026-05-14	5,403	$3.99	$22K
2026-04-16	231	$2.78	$642
2026-04-13	1,604	$2.46	$4K
2026-04-07	1,044	$2.61	$3K
2026-04-06	10,382	$2.75	$29K
2026-04-02	15	$3.12	$47

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for INBS in the last 90 days. The most recent filings are listed below. Latest filing: Sakiris Spiro Kevin (Chief Financial Officer) on 2026-03-18.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-03-18	Sakiris Spiro Kevin	Chief Financial Officer	Grant	21K	$0.00	$0	34K
2026-03-18	Sakiris Spiro Kevin	Chief Financial Officer	Grant	9K	$0.00	$0	13K
2026-03-18	Isenberg Jason	Director	Grant	5K	$0.00	$0	5K
2026-03-18	Simeonidis Harry	Chief Executive Officer	Grant	21K	$0.00	$0	35K
2026-03-18	Simeonidis Harry	Chief Executive Officer	Grant	9K	$0.00	$0	13K
2026-03-18	Hurd Jonathan Scott	Director	Grant	5K	$0.00	$0	5K
2026-03-18	Fraser Nicola Marion	Director	Grant	5K	$0.00	$0	5K
2026-03-18	Boyages Steven Constantine	Director	Grant	5K	$0.00	$0	5K
2024-09-25	Sakiris Spiro Kevin	Chief Financial Officer	Grant	35K	$0.00	$0	35K
2024-09-25	Simeonidis Harry	Chief Executive Officer	Grant	40K	$0.00	$0	40K
2024-03-20	Sakiris Spiro Kevin	Chief Financial Officer	Exercise (in or at the money)	9K	price not stated in the filing	not stated	19K
2023-10-04	Sakiris Spiro Kevin	Chief Financial Officer	Buy	113K	$0.55	$62K	117K
2023-10-04	TOWERS CHRISTOPHER	Director	Buy	9K	$0.55	$5K	10K
2023-09-01	Simeonidis Harry	CEO	Buy	50	$1.85	$93	4K
2023-08-31	Simeonidis Harry	CEO	Buy	100	$1.92	$192	4K
2023-05-10	Sakiris Spiro Kevin	Chief Financial Officer	Conversion	2K	$5.80	$14K	5K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

5 holders report 5% or more of INBS in their latest filing, all on Schedule 13G (passive). The largest reported stake is Alyeska Investment Group, L.P. at 10.0% of the class (944,310 shares), filed 2025-11-14 for an event on 2025-09-30.

Filed	Form	Holder	Shares	Of class	Event
2026-08-14	13G/Ano. 1	Armistice Capital, LLCinvestment adviser, other entity	141K	5.9%	2026-06-30
2026-08-14	13G/Ano. 1	Steven Boydparent holding company, individual	141K	5.9%	2026-06-30
2025-11-14	13G/Ano. 1	Alyeska Investment Group, L.P.investment adviser	944K	10.0%	2025-09-30
2025-11-14	13G/Ano. 1	Alyeska Fund GP, LLCother entity	944K	10.0%	2025-09-30
2025-11-14	13G/Ano. 1	Anand Parekhindividual	944K	10.0%	2025-09-30

What this page is

Intelligent Bio Solutions in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Intelligent Bio Solutions (INBS), SEC CIK 1725430, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest: FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
Earnings dates: SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-19.JSON and CSV
Insider trades: SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-03-18.JSON and CSV
Company record: EDGAR filing index for CIK 1725430Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 10 requests a minute without a key, 30 with a free key from a free account.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of INBS is sold short?

91,113 shares were held short at the 2026-10-15 settlement, 1.4 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is INBS's daily short volume?

On 2026-11-02, 2,609 of the 14,606 INBS shares reported to FINRA were sold short, 17.9% of the day's reported volume. Short volume is a flow for one day, not a position.

Does INBS have fails to deliver?

The SEC's latest file shows 1,807 INBS shares failed to deliver at settlement 2026-10-14. Fails are reported per settlement date and published twice a month with a lag.

Are INBS insiders buying or selling?

No open-market insider trades were reported for INBS in the last 90 days. The most recent filings are listed below. Latest filing: Sakiris Spiro Kevin (Chief Financial Officer) on 2026-03-18.

Who owns 5% or more of INBS?

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.

Intelligent Bio Solutions (INBS)

Short interest

Daily short volume

Fails to deliver

Insider trades

Large holders (13D and 13G)

Intelligent Bio Solutions in the regulatory record

Source and updates

How to read it

Other company pages

Datasets

Frequently Asked Questions